These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4145866)
61. Long-term care of schizophrenia. Loranger AW; Hollister LE N Engl J Med; 1972 Sep; 287(10):518-9. PubMed ID: 4625986 [No Abstract] [Full Text] [Related]
62. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia. Tanghe A; Vereecken JL Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564 [No Abstract] [Full Text] [Related]
63. Clinical comparison of two beta-receptor stimulants and one parasympatholytic drug in chronic obstructive lung disease. Kreukniet J Scand J Respir Dis; 1971; 52(3):137-44. PubMed ID: 4949896 [No Abstract] [Full Text] [Related]
64. [Comparative study of Navane concentrate and tablets]. Radmayr E Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):340-60. PubMed ID: 4241209 [No Abstract] [Full Text] [Related]
65. [Clinical evaluation of pipothiazine and its palmitic ester in the therapy of schizophrenia]. Costa JG; Silva E; Dreyfus JF Ann Med Psychol (Paris); 1981 Apr; 139(4):439-45. PubMed ID: 6118086 [TBL] [Abstract][Full Text] [Related]
66. Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesia. Mosnaim AD; Wolf ME J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):27S-30S. PubMed ID: 2906066 [TBL] [Abstract][Full Text] [Related]
67. Clinical studies with propericiazine (R.P. 8909). St Jean A; Sterlin C; Noe W; Ban TA Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004 [No Abstract] [Full Text] [Related]
68. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity. Donlon PT; Rada RT Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106 [TBL] [Abstract][Full Text] [Related]
69. Drug responses of three hospital population samples participating in a collaborative study. Crane GE; Krummholz W; Lichtigfeldt FJ; Salim T Arzneimittelforschung; 1966 Feb; 16(2):290-3. PubMed ID: 4383294 [No Abstract] [Full Text] [Related]
70. [Parenteral form of pipothiazine in the treatment of endogenous psychoses]. Matkowski K; Martenka E; Nobis T Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666 [No Abstract] [Full Text] [Related]
71. A clinical evaluation of fluphenazine enanthate. Goldberg HL; DiMascio A; Chaudhary B Dis Nerv Syst; 1970 Sep; 31():Suppl:46-7. PubMed ID: 5476358 [No Abstract] [Full Text] [Related]
72. [Comparative study of 2 drugs and a placebo in chronic schizophrenia]. Tetreault L Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120 [No Abstract] [Full Text] [Related]
74. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow. Hollister LE Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921 [No Abstract] [Full Text] [Related]
75. A follow-up study of intensively treated chronic schizophrenic patients. Messier M; Finnerty R; Botvin CS; Grinspoon L Am J Psychiatry; 1969 Feb; 125(8):1123-7. PubMed ID: 5794854 [No Abstract] [Full Text] [Related]